| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/14/2002 | CA2267186C Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 05/10/2002 | WO2002036662A1 Organic polymer and novel polymerizable compound |
| 05/10/2002 | WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | WO2002036162A2 Compositions for treatment of ocular neovascularization and neural injury |
| 05/10/2002 | WO2002036116A2 Tripeptidyl peptidase inhibitors |
| 05/10/2002 | WO2001026629A3 Neutral-cationic lipid for nucleic acid and drug delivery |
| 05/10/2002 | WO2001019799A3 Nitroimidazole derivative and diagnostic imaging agent containing the same |
| 05/10/2002 | CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/09/2002 | US20020055643 Tubulin binding ligands and corresponding prodrug constructs |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055045 Novel materials useful as electrolytic solutes |
| 05/08/2002 | EP1203782A1 Imidazole-Phosphoric acid salts as accelerators for dicyandiamide in one-component epoxy compositions |
| 05/08/2002 | EP1203781A1 2-phenylimidazole-phosphoric acid salt as an accelerator for acid anhydride curatives in one-component epoxy compositions |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202973A1 Preparation of compounds useful for the detection of hypoxia |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202956A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
| 05/08/2002 | EP1202945A1 Methods for preparing perfluorinated [18 f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| 05/08/2002 | DE10053796A1 Aminonaphthalene N-phenylsulfonamide derivatives, useful for treating central nervous system disorders, e.g. Alzheimer's disease, dementia, Parkinson's disease, are 5-HT6 receptor antagonists |
| 05/08/2002 | CN1348500A Novel method for preparing synthesis intermediates |
| 05/08/2002 | CN1348446A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1347878A Halogenated pyrimidines and its application as a method for reducing parasite |
| 05/08/2002 | CN1084396C Silver plating bath and silver plating method with the same bath |
| 05/07/2002 | US6384284 Reacting a diphenylbisaldehyde in the presence of a base or lewis acid; photostabilizers for cosmetics and drugs |
| 05/07/2002 | US6384232 Radiology, hypoxic tissue cytotoxins, radiosensitizers; react n-(2,3-epoxypropyl)phthalimide with 2-nitro-imidazole; 6-((2-nitro-1h-imidazol-1-yl)methyl)-5-oxa-4,8-diaza undecane-2,10-dione dioxime compounds |
| 05/07/2002 | US6384216 Purification of alkenyl compounds |
| 05/07/2002 | US6384068 Imidazole containing compounds having relatively low hydrogen content and relatively high nitrogen content and polymers and copolymers formed therefrom |
| 05/07/2002 | US6384067 Fungicidal compositions comprising a 2-imidazolin-5-one |
| 05/07/2002 | US6384062 Pharmaceutical composition |
| 05/07/2002 | US6384061 Hydantoin compounds and methods related thereto |
| 05/07/2002 | US6384056 Cognition activators and nerve and vision disorders |
| 05/07/2002 | US6384042 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes |
| 05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 05/07/2002 | US6383230 Cationic monobenzenic dyes, their use for the oxidation-dyeing of keratin fibers, dye compositions and dyeing processes |
| 05/02/2002 | WO2002042244A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 05/02/2002 | WO2002034722A1 Imidazolium salts and their use of these ionic liquids as a solvent |
| 05/02/2002 | WO2002034711A1 Biaryl compounds as serine protease inhibitors |
| 05/02/2002 | WO2002034698A2 Phosgene-free process for preparing carbamates |
| 05/02/2002 | WO2001087848A3 Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds |
| 05/02/2002 | WO2001039762A3 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |
| 05/02/2002 | US20020052511 Process for the preparation of matrix metalloproteinase inhibitors |
| 05/02/2002 | US20020052508 Heterocyclic thioamide derivatives |
| 05/02/2002 | US20020052482 Covalently linked oligonucleotide minor grove binder conjugates |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052392 Have utility as, inter alia, hypoglycemic, and anti-obesity agents. |
| 05/02/2002 | US20020052390 Treating non-invasive fungus-induced otitis media by mucoadministering an antifungal agent. |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052376 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 05/02/2002 | US20020052366 Administering taurolidine, taurultam, or a biologically active derivative; induces tumor cell death by apoptosis. |
| 05/02/2002 | EP1201657A1 Imidazolium salts and the use of these ionic liquids as a solvent and as a catalyst |
| 05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
| 05/02/2002 | EP1200430A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth |
| 05/02/2002 | EP1200427A2 Small molecule modulators of g protein-coupled receptor six (gpr6) |
| 05/02/2002 | EP1200412A2 Imidazole antiproliferative agents |
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP1076718B1 Novel method for preparing synthesis intermediates |
| 05/02/2002 | CA2427473A1 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 05/02/2002 | CA2426466A1 Phosgene-free process for preparing carbamates |
| 05/02/2002 | CA2426430A1 Biaryl compounds as serine protease inhibitors |
| 05/01/2002 | CN1083838C Novel imidazole derivs., method for preparing same, use as medicine, and pharmaceutical compositions contg. same |
| 04/30/2002 | US6380403 Illudin analogs useful as antitumor agents |
| 04/30/2002 | US6380396 Chemical intermediates for antiinflammatory agents |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380256 For therapy of diseases responsive to treatment by retinoids |
| 04/30/2002 | US6380237 Diphenylimidazolines |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380213 Compounds useful as neuro-protective agents |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/30/2002 | US6379882 Exposing a primary culture of retinal ganglion cells to an oxygen/glucose deprivation challenge with and without a test compound; after an incubation period, measure the percentage of apoptotic cells |
| 04/30/2002 | US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation |
| 04/30/2002 | US6379634 Dissolving in a solvent a material in an initial oxidation state below its maximum oxidation state, wherein the solvent oxidizes it to a higher oxidation state; nuclear fuels |
| 04/30/2002 | US6379588 Stabilized monomer composition |
| 04/30/2002 | US6379398 Aromatic diamines as hair dyes |
| 04/25/2002 | WO2002033110A2 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 04/25/2002 | WO2002032897A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 04/25/2002 | WO2002032878A1 Resolution process for preparation of substantially pure (r) and (s) enantiomers of 2-(4-nitroimidazolyl)-4-methoxyphenylpropionic acid and salts thereof |
| 04/25/2002 | WO2002032877A2 Process for preparation of n-substituted 2-sulfanylimidazoles |
| 04/25/2002 | WO2002032876A2 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032856A2 Insecticidal 1,8-naphthalenedicarboxamides |
| 04/25/2002 | WO2002032844A2 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives |
| 04/25/2002 | WO2002032376A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 04/25/2002 | WO2001097810A3 Use of therapeutic benzamide derivatives |
| 04/25/2002 | US20020049344 New vitamin d derivatives with carbo-or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
| 04/25/2002 | US20020049241 Conformationally rigid bicyclic and adamantane derivatives useful as alpha2-adrenergic blocking agents |
| 04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/25/2002 | US20020049228 2-Sulfamoylbenzoic acid derivatives |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression |
| 04/25/2002 | US20020049211 Combination treatment for depression and anxiety |
| 04/25/2002 | US20020049200 Use of a methylol-containing compound to treat tumors |
| 04/25/2002 | DE10050723A1 New N-substituted amino acid derivatives for treating thromboembolic diseases e.g. thrombosis, myocardial infarct, arteriosclerosis, inflammation, stroke, angina, restenosis are factor Xa inhibitors |
| 04/25/2002 | CA2426594A1 Production of .alpha.-hydroxy-carboxylic acids using a coupled enzyme system |